DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/836bsh/competing_in_the) has announced the addition of the "Competing in the Global Blood Banking Market" report to their offering.
This new 800-page seven-country study from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.
Rationale
During the next five years, the transfusion diagnostics market will undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.
The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.
Geographic Coverage
- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA
The report explores future marketing and technological trends in the US, Europe and Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years.
Companies Mentioned
- Abbott
- Beckman Coulter/Danaher
- Bio-Rad
- BioMerieux
- Gen-Probe
- Grifols
- Immucor
- Nanosphere
- Ortho-Clinical Diagnostics
- Roche
- Sarstedt
- Siemens
- Tecan
For more information visit http://www.researchandmarkets.com/research/836bsh/competing_in_the